ORIC PHARMACEUTICALS
ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s lead product candidate,ORIC-101, is a potent and selective small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across a variety of solid tumors. ORIC’s second product candidate, ORIC-533, is an orally bioavailable small molecule inhibitor of CD73, a key node i... n the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens. Beyond these two product candidates, ORIC is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC’s scientific founders, Charles Sawyers, MD, and Scott Lowe, PhD, have long records of discovering novel targets in cancer that have led to innovative treatments.
ORIC PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2014-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.oricpharma.com
Total Employee:
101+
Status:
Active
Contact:
(650)388-5600
Total Funding:
173 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins
Similar Organizations
Acasti Pharma
Acasti Pharma is an emerging biopharmaceutical company.
Acerus Pharmaceuticals
Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company.
Alltrna
Alltrna is the creator of a tRNA platform that aims to decipher tRNA biology and pioneer therapies for disease treatment.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Basilea Pharmaceutica
Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company.
Biocytogen
Biopharmaceutical company.
Bond Biosciences
Bond Biosciences is a biopharmaceutical company
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Cycle Pharmaceuticals
Cycle Pharmaceuticals is a pioneering pharmaceutical company.
FastFarma
FastFarma operates as a digital pharmacy.
Purple Biotech
Purple Biotech is an innovative biopharmaceutical drug development company.
MailMyPrescriptions.com
Online Pharmacy | America's First Wholesale Pharmacy Service
OncoQuest
OncoQuest is a Edmonton-based biopharmaceutical company.
Caraway Therapeutics
Rheostat Therapeutics is a bio therapeutics company.
Zhaoke Ophthalmology Pharmaceutical
Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.
ZWI Therapeutics, Inc.
ZWI Therapeutics is a biotech company developing a new polymer to reduce immunogenicity and aid pharmacokinetics of protein therapeutics.
Current Advisors List
Board_member
Board_member
2014-11-01
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Pratik Multani Chief Medical Officer @ ORIC Pharmaceuticals
Chief Medical Officer
Edna Chow Maneval Senior Vice President, Clinical Development @ ORIC Pharmaceuticals
Senior Vice President, Clinical Development
2019-03-01
Jacob Chacko President & Chief Executive Officer @ ORIC Pharmaceuticals
President & Chief Executive Officer
2018-04-01
Lori Friedman Chief Scientific Officer @ ORIC Pharmaceuticals
Chief Scientific Officer
2019-07-01
Charles Sawyers Founder @ ORIC Pharmaceuticals
Founder
Dominic Piscitelli Chief Financial Officer @ ORIC Pharmaceuticals
Chief Financial Officer
2019-09-01
Sara Coblin Vice President, Finance & Operations @ ORIC Pharmaceuticals
Vice President, Finance & Operations
Matthew Panuwat Chief Business Officer @ ORIC Pharmaceuticals
Chief Business Officer
2018-11-01
Scott Lowe Founder @ ORIC Pharmaceuticals
Founder
Founder
Stock Details
Investors List
Taiho Ventures
Taiho Ventures investment in Series D - ORIC Pharmaceuticals
Casdin Capital
Casdin Capital investment in Series D - ORIC Pharmaceuticals
Correlation Ventures
Correlation Ventures investment in Series D - ORIC Pharmaceuticals
Invus
Invus investment in Series D - ORIC Pharmaceuticals
Irving Investors
Irving Investors investment in Series D - ORIC Pharmaceuticals
Memorial Sloan - Kettering Cancer Center
Memorial Sloan - Kettering Cancer Center investment in Series D - ORIC Pharmaceuticals
OrbiMed
OrbiMed investment in Series D - ORIC Pharmaceuticals
Hartford HealthCare Endowment
Hartford HealthCare Endowment investment in Series D - ORIC Pharmaceuticals
City Hill Ventures
City Hill Ventures investment in Series D - ORIC Pharmaceuticals
Topspin Partners
Topspin Partners investment in Series D - ORIC Pharmaceuticals
Official Site Inspections
http://www.oricpharma.com Semrush global rank: 3.82 M Semrush visits lastest month: 3.48 K
- Host name: 249.28.212.35.bc.googleusercontent.com
- IP address: 35.212.28.249
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "ORIC Pharmaceuticals"
About - ORIC Pharmaceuticals
Resistance limits the efficacy of otherwise significant cancer treatment breakthroughs, regardless of modality. Our ambition at ORIC is to discover and develop innovative therapies that benefit patients with cancer, including by …See details»
Careers - ORIC Pharmaceuticals
ORIC® is a science-driven, clinical stage company dedicated to discovering and developing novel therapies to improve patients’ lives by Overcoming Resistance In Cancer. We offer a …See details»
ORIC Pharmaceuticals - Crunchbase Company Profile …
Contact Email info@oricpharma.com Phone Number (650)388-5600 ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer.See details»
ORIC Pharmaceuticals Inc. Management Team | Org Chart
Oricpharma.com; 2 908264XXXX; 858349XXXX; View Similar People. Related Companies California Life Sciences (CLS) 112 Genome Medical. 97 Mission Bio. 97 $31.1m Tizona …See details»
ORIC® Pharmaceuticals Reports First Quarter 2025 Financial …
For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn. Cautionary Note Regarding Forward-Looking Statements This press release contains forward …See details»
ORIC Pharmaceuticals Inc. - LinkedIn
ORIC Pharmaceuticals Inc. Biotechnology Research South San Francisco, California 7,227 followers Overcoming Resistance In CancerSee details»
Oric Pharmaceuticals - Overview, News & Similar companies
Jun 7, 2024 Oric Pharmaceuticals contact info: Phone number: (650) 388-5600 Website: www.oricpharma.com What does Oric Pharmaceuticals do? ORIC Pharmaceuticals is a …See details»
ORIC Pharmaceuticals Inc Company Profile - GlobalData
ORIC Pharmaceuticals Inc (ORIC) is a clinical-stage pharmaceutical company. It focuses on therapies to treat cancer. The company’s pipeline product pipeline includes ORIC-533, a orally …See details»
ORIC Pharmaceuticals CEO and Key Executive Team | Craft.co
ORIC Pharmaceuticals's President, Chief Executive Officer and Board Member is Jacob Chacko. Other executives include Lori Friedman, Chief Scientific Officer; Pratik Multani, Chief Medical …See details»
ORIC Pharmaceuticals - Craft
Oct 29, 2024 ORIC is a pharmaceutical company dedicated to discovering and developing therapies towards overcoming resistance in cancer. It offers a small molecule antagonist of the …See details»
Working At ORIC Pharmaceuticals: Company Overview and Culture …
Mar 14, 2024 oricpharma.com. Organization Type. Public. Social Media. ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to improving patients' lives by …See details»
ORIC Pharmaceuticals
Apr 28, 2025 ORIC Pharmaceuticals was founded in 2007 and is located in San Francisco, California. The company was created to focus on improving the lives of cancer patients and …See details»
ORIC Pharmaceuticals Appoints Steven L. Hoerter to its Board of ...
For more information, please go to www.oricpharma.com, and follow us on Twitter or LinkedIn. Cautionary Note Regarding Forward-Looking Statements This press release contains forward …See details»
ORIC Pharmaceuticals Outlines Clinical Development Plans and
7 hours ago info@oricpharma.com. ORIC PHARMACEUTICALS, INC. CONDENSED BALANCE SHEETS (in thousands, except share and per share amounts) March 31, 2025: December 31, …See details»
ORIC Pharmaceuticals Inc: Locations - GlobalData
View ORIC Pharmaceuticals Inc's company headquarters address along with its other key offices and locations.See details»
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 ...
Feb 18, 2025 For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn. Cautionary Note Regarding Forward-Looking Statements This press release …See details»
ORIC® Pharmaceuticals Reports First Quarter 2025 ... - Morningstar
1 day ago ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on ...See details»
about - ORIC Pharmaceuticals
©ORIC Pharmaceuticals, Inc. All rights reserved. ORIC and the stylized ORIC mark are registered trademarks of ORIC Pharmaceuticals, Inc.See details»
ORIC Pharmaceuticals Outlines Strategic Development Plans for
Feb 25, 2025 ORIC Pharmaceuticals outlines clinical development plans for ORIC-944 and ORIC-114, targeting high unmet needs in mCRPC and NSCLC. Quiver AI SummarySee details»
ORIC® Pharmaceuticals Announces Focused Registrational Clinical ...
For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn. Cautionary Note Regarding Forward-Looking Statements This press release contains forward …See details»